Floatz logo

Daptomycin

Infection

OHSU Knight Cancer Instituteprotein_peptidePhase 2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Infection cohort.

Asset / SponsorPhaseRating
SULFAMETHOXAZOLE
Radboud University Medical Center
Phase 4A
Trimethoprim
Radboud University Medical Center
Phase 4A
Ciprofloxacin
Radboud University Medical Center
Phase 4BBB
AMDINOCILLIN
Radboud University Medical Center
Phase 4BB
Aztreonam
Liverpool Heart and Chest Hospital NHS Foundation Trust
Phase 4BB

View all 50 →

Same molecule, other indications

Daptomycin is also rated in:

FeverDormant
CCC
Indicative ·
52 / 100
View asset →
AscitesDormant
CCC
Indicative ·
52 / 100
View asset →
hematopoietic and lymphoid cell neoplasmDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →